Apogee Therapeutics, Inc. (APGE) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $131.55M | -7.2% |
| 2024 | $141.79M | +19.8% |
| 2023 | $118.32M | -22.1% |
| 2022 | $151.89M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $131.55M | -7.2% |
| 2024 | $141.79M | +19.8% |
| 2023 | $118.32M | -22.1% |
| 2022 | $151.89M | — |